Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subharmonic Breast Imaging for Monitoring Neoadjuvant Chemotherapy
NCT02115607Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Mar 2014
- Primary completion
- May 2018
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of perflutren lipid microspheres in breast cancer, sponsored by Sidney Kimmel Comprehensive Cancer Center. Primary endpoints: Subharmonic Aided Pressure Estimation After Treatment for Complete Responders at 6 months and Subharmonic Aided Pressure Estimation After Treatment for Partial Responders at 6 months. Started Mar 2014; status: completed.
02
Drugs
perflutren lipid microspheres
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02115607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02115607.